Web Results

en.wikipedia.org/wiki/Abraxis_BioScience

Abraxis BioScience was a global biopharmaceutical company that developed treatments for critically ill patients. It had over 2000 employees worldwide inb 2007 ...

califesciences.org/abraxis-bioscience-inc

From the discovery and research phase to development and commercialization, Abraxis BioScience is committed to rapidly enriching the company's pipeline ...

www.manta.com/c/mtccfvt/abraxis-bioscience-llc

Get information, directions, products, services, phone numbers, and reviews on Abraxis Bioscience in Los Angeles, CA. Discover more Pharmaceutical ...

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=36219009

Abraxis BioScience, Inc. develops, manufactures, and markets protein-based therapeutics and technologies for treatment of cancer and other critical illnesses.

ir.celgene.com/releasedetail.cfm?releaseid=799482

Jun 30, 2010 ... Celgene Corporation (NASDAQ: CELG)and Abraxis BioScience Inc. (Nasdaq: ABII) today jointly announced the signing of a definitive merger ...

www.celgene.com

Learn how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and ...

www.linkedin.com/company/abraxis-bioscience

Learn about working at Abraxis BioScience. Join LinkedIn today for free. See who you know at Abraxis BioScience, leverage your professional network, and get ...

bciq.biocentury.com/companies/abraxis_bioscience_inc

NantBioscience Inc. raised $100 million in equity financing, according to an SEC NantWorks LLC, is developing a pipeline of targeted therapies based on ...

www.fiercebiotech.com/special-report/abraxis-bioscience-biotech-s-biggest-spenders

Based: Abraxis Bioscience R&D budget: $146 million (€107M)Change from 08: + 49.3%Income spent on R&D: 43.1% You won't see Abraxis on ... As we noted, Celgene bought out Abraxis for $2.9 billion earlier this year. ... 2018 Questex LLC .